Clinical Trial Update: Phase III Double-blind Comparative Study of BAY77-1931 (Lanthanum Carbonate) With Calcium Carbonate [Phase 3]

View source ↗

Summary

A Phase 3 double-blind trial comparing lanthanum carbonate (BAY77-1931) with calcium carbonate for hyperphosphatemia has completed. The study was sponsored by B…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperphosphatemia

Drugs mentioned

• Calcium carbonate (Calcium carbonate)
• Lanthanum Carbonate (BAY77-1931) (lanthanum carbonate)

Snippet

Sponsor: Bayer | Conditions: Hyperphosphatemia | Phase 3 | Status: COMPLETED